A Phse Ii Trial Of Imatinib (Im) In Relapsed, Nonresectable Chondrosarcoma (Cs) Expressing Platelet-Derived Growth Factor Receptor-Alpha Or -Beta (Pdgfr-Alpha/Pdgfr-Beta): An Italian Sarcoma Group Study

G. Grignani, E. Palmerini,S. Stacchiotti, A. Boglione, V. Ferraresi, S. Frustaci, A. Comandone, P. G. Casali,S. Ferrari, M. Aglietta

Journal of Clinical Oncology（2010）

引用 2|浏览12

暂无评分

摘要

10060 Background: CS is a rare and heterogeneous disease in which, after failure of surgery and radiotherapy, chemotherapy has a marginal role, if any. Different molecular pathways were shown to be...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要